Acamprosate


  Issues for Surgery


Risk of alcohol relapse if omitted.


  Advice in the Perioperative period


Elective and Emergency Surgery

Continue.


Post-operative Advice

Restart post-operatively as soon as next dose is due.

Monitor renal function – dose reduction may be necessary if renal function is impaired (consult current product literature)1.


  Interaction(s) with Common Anaesthetic Agents

 

None1,2,3.


  Interaction(s) with other Common Medicines used in the Perioperative Period

 

None1,2,3.


  Further Information


None relevant.


  References


  1. Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press. http://www.medicinescomplete.com [Accessed on 4th November 2020]
  2. Summary of Product Characteristics – Acamprosate 333mg Gastro-resistant Tablets. Mylan. Accessed via www.medicines.org.uk 04/11/2020 [date of revision of the text June 2020]
  3. Baxter K, Preston CL (eds), Stockley’s Drug Interactions (online) London: Pharmaceutical Press. http://www.medicinescomplete.com [Accessed on 4th November 2020]